🇺🇸 FDA
Patent

US 11536727

Therapeutic antibodies against ROR-1 protein and methods for use of same

granted A61KA61K2039/505A61P

Quick answer

US patent 11536727 (Therapeutic antibodies against ROR-1 protein and methods for use of same) held by The Regents of the University of California expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P35/02